Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15807 articles
Association of sleep duration and depressive symptoms with mortality in cancer survivors
Cancer survivors with depressive symptoms had higher risk of all-cause mortality when sleeping.
»
12/24/24
Mitochondrial transcription elongation factor TEFM promotes malignant progression of gliomas
TEFM knockout effectively suppressed growth of subcutaneous glioma xenografts in nude mice.
»
12/24/24
Examining the factor structure of the Pittsburgh Sleep Quality Index and its determinants among GI cancer patients
PSQI encompasses two factors (perceived sleep quality and sleep disturbances) in GI cancer patients.
»
12/26/24
Protein kinase CK2 sustains de novo fatty acid synthesis by regulating the expression of SCD-1 in human renal cancer cells
Inhibition of CK2 results in significant accumulation of saturated palmitic and stearic acids.
»
12/26/24
Sensitive liquid biopsy monitoring correlates with outcome in the prospective international GPOH-DCOG high-risk neuroblastoma RT-qPCR validation study
Post-induction immunocytology positivity not associated with EFS or OS.
»
12/26/24
Depression risk among breast cancer survivors: a nationwide cohort study in South Korea
Endocrine therapy showed 41% increased depression risk in older survivors.
»
12/27/24
THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer
Crucial role of THBS2 + CAFs in promoting oxaliplatin resistance of CRC.
»
12/28/24
Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study
Combination therapy with palbociclib or ribociclib with ET partner has similar efficacy and is safe.
»
12/30/24
Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-Medicare
Both HER2 + and HR −/HER2 − patients showed slower, approximately linear growth in sHR.
»
12/30/24
Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation
USP39 knockdown inhibits clonogenic capacity, induces cell cycle arrest and triggers apoptosis.
»
12/30/24
< Prev
Next >